January/February

Interview With Andrew Pecora, MD, CPE, President, Regional Cancer Care Associates, Chief Innovations Officer and Vice President, Cancer Services, John Theurer Cancer Center at Hackensack University Medical Center

The Role of Companion Diagnostic Testing in Payer Decision Making

ByJerry Conway

February 26th 2013

Literature Review: Chronic Myeloid Leukemia

February 26th 2013

Lessons From an Oncology Medical Home Collaborative

ByJohn Fox, MD, MHA

February 25th 2013

January/February

Literature Review: Melanoma

Crossroads in Breast Cancer: The Intersection of Clinical Uncertainty and Molecular Profiling

ASH Conference Coverage

Managed Care Restrictions: Barriers to Product Use in Cancer Care

Partial Fill Strategies for Oral Oncolytics to Reduce Waste and Drive Persistency

From Bench to Bedside: Promising Colon Cancer Clinical Trials

The Future of Oncology? COME HOME, the Oncology Medical Home

Focusing on Clinical and Economic Outcomes-Not Guidelines

The Role of Companion Diagnostic Testing in Payer Decision Making

Literature Review: Chronic Myeloid Leukemia

Lessons From an Oncology Medical Home Collaborative

Trending on AJMC

FDA Approves Belantamab Mafodotin Combo for Relapsed or Refractory Multiple Myeloma

IEHP CEO Weighs in: Who Pays the Price When Millions Lose Medicaid Coverage?

Guidelines for Bronchiectasis Highlight Multiple Treatment Methods

Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits

Belantamab Mafodotin Can Help Fill Access Gaps in BCMA-Directed Myeloma Therapy: Hearn Jay Cho, MD, PhD